Cytokines, endothelium, and adhesive molecules in pathologic thrombopoiesis

Clinical and Applied Thrombosis/Hemostasis

Volumn 7, Issue 2, 2001, Pages 126-130

  Cobankara, Veli ^a   Oran, Betul ^c   Ozatli, Duzgun ^c   Haznedaroglu, Ibrahim Celalettin ^b   Kosar, Ali ^c   Buyukasik, Yahya ^c   Ozcebe, Osman ^c   Dundar, Semra ^c   Kirazli, Serafettin ^c  

^a Departirients of Rheumatology   (Turkey)

^b Internal Medicine Department   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Cytokines; Myeloproliferative disorders; Thrombocythemia; Thrombocytosis; Thrombomodulin

Indexed keywords

CELL ADHESION MOLECULE; CYTOKINE; FIBRONECTIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; THROMBOMODULIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM LESION; FEMALE; HUMAN; MALE; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; THROMBOCYTE METABOLISM; THROMBOCYTHEMIA; THROMBOCYTOPOIESIS; THROMBOCYTOSIS;

CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; CYTOKINES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MYELOPROLIFERATIVE DISORDERS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; STATISTICS, NONPARAMETRIC; THROMBOCYTOSIS;

EID: 0035078151     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960100700209     Document Type: Article

References (29)

1. Growth factors affecting human thrombocytopoiesis: Potential agents for the treatment of thrombocytopenia
2. Regulation of megakaryocytopoiesis
3. Human hematopoietic stem cells adherence to cytokines and matrix molecules
4. Thrombospondin functions as a cytoadhesion molecule for human hematopoietic progenitor cells
5. Population heterogeneity among cells of the megakaryocytic lineage
6. The regulation of natural anticoagulant pathways
7. Structure and function of thrombomodulin. A natural anticoagulant
8. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells
9. Increased levels of plasma thrombomodulin in chronic myelogenous leukemia
10. Soluble plasma levels in patients with chronic myeloproliferative disorder
11. Conditions controlling the proliferation of haemotopoietic stem cells in vitro
12. Extracellular matrix production by the adherent cells of long-term murine bone marrow cultures
13. Adhesion receptors of immune system
14. Leukocyte-endothelial adhesion molecules
15. Effect of interleukin 6 on in vitro human megakaryocytopoiesis: Its interaction with other cytokines
16. Human interleukin-6 is a direct promoter of maturation of magakaryocytes in vitro
17. Multiple in vivo effects of interleukin-3 and interleukin-6 on murine magakaryocytopoiesis
18. A phase-I trial of recombinant human interleukin-6 in patients with myelodysplastic syndromes and thrombocytopenia
19. Megakaryocytopoietic cytokines in autoimmune thrombocytopenic purpura
20. Interleukin-1 and interleukin-6 in clonal versus reactive thrombocytosis
21. Plasma interleukin-6 and c-reactive protein levels in reactive versus clonal thrombocytosis
22. Interleukin-1, tumor necrosis factor, and the production of colony-stimulating factors by cultured mesenchymal cells
23. Tumor necrosis factor suppresses transcription of the thrombomodulin in endothelial cells
24. Plasma thrombomodulin in health and diseases
25. Establishment of enzyme immunoassay of human thrombomodulin in plasma and urine using monoclonal antibodies
26. Plasma levels of soluble plasma thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure
27. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation
28. Increased levels of plasma thrombomodulin in chronic myelogenous leukemia
29. De nova expression of intracellular adhesion molecule 1 in melanoma correlates with increased risk of metastasis